1. Munck, A., Guyre, P.M. and Holbrook, N.J. (1984) Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr Rev 5, 25-44.

2. Clark, J.K., Schrader, W.T. and O'Malley, B.W. (1992) Mechanism of steroid hormones. In: Williams Textbook of Endocrinology (Wilson, J.D. and Foster, D.W., eds.), pp. 35-90, WB Sanders Co., Philadelphia.

3. Boumpas, D.T., Chrousos, G.P., Wilder, R.L., Cupps, T.R. and Balow, J.E. (1993) Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates. Ann Intern Med 119, 1198-1208.

4. Galon, J., Franchimont, D., Hiroi, N., Frey, G., Boettner, A., Ehrhart-Bornstein, M., O'Shea, J.J., Chrousos, G.P. and Bornstein, S.R. (2002) Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. Faseb J 16, 61-71.

5. Mangelsdorf, D.J., Thummel, C., Beato, M., Herrlich, P., Schutz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P. and et al. (1995) The nuclear receptor superfamily: the second decade. Cell 83, 835-839.

6. Hollenberg, S.M., Weinberger, C., Ong, E.S., Cerelli, G., Oro, A., Lebo, R., Thompson, E.B., Rosenfeld, M.G. and Evans, R.M. (1985) Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature 318, 635-641.

7. Bamberger, C.M., Bamberger, A.M., de Castro, M. and Chrousos, G.P. (1995) Glucocorticoid receptor β, a potential endogenous inhibitor of glucocorticoid action in humans. J Clin Invest 95, 2435-2441.

8. Lewis-Tuffin, L.J., Jewell, C.M., Bienstock, R.J., Collins, J.B. and Cidlowski, J.A. (2007) Human glucocorticoid receptor β binds RU-486 and is transcriptionally active. Mol Cell Biol 27, 2266-2282.

9. Almlof, T., Gustafsson, J.A. and Wright, A.P. (1997) Role of hydrophobic amino acid clusters in the transactivation activity of the human glucocorticoid receptor. Mol Cell Biol 17, 934-945.

10. Almlof, T., Wallberg, A.E., Gustafsson, J.A. and Wright, A.P. (1998) Role of important hydrophobic amino acids in the interaction between the glucocorticoid receptor tau 1-core activation domain and target factors. Biochemistry 37, 9586-9594.

11. Warnmark, A., Gustafsson, J.A. and Wright, A.P. (2000) Architectural principles for the structure and function of the glucocorticoid receptor tau 1 core activation domain. J Biol Chem 275, 15014-15018.

12. Kumar, R., Volk, D.E., Li, J., Lee, J.C., Gorenstein, D.G. and Thompson, E.B. (2004) TATA box binding protein induces structure in the recombinant glucocorticoid receptor AF1 domain. Proc Natl Acad Sci U S A 101, 16425-16430.

13. Howard, K.J., Holley, S.J., Yamamoto, K.R. and Distelhorst, C.W. (1990) Mapping the HSP90 binding region of the glucocorticoid receptor. J Biol Chem 265, 11928-11935.

14. Schule, R., Rangarajan, P., Kliewer, S., Ransone, L.J., Bolado, J., Yang, N., Verma, I.M. and Evans, R.M. (1990) Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor. Cell 62, 1217-1226.

15. Bledsoe, R.K., Montana, V.G., Stanley, T.B., Delves, C.J., Apolito, C.J., McKee, D.D., Consler, T.G., Parks, D.J., Stewart, E.L., Willson, T.M., Lambert, M.H., Moore, J.T., Pearce, K.H. and Xu, H.E. (2002) Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition. Cell 110, 93-105.

16. Tanenbaum, D.M., Wang, Y., Williams, S.P. and Sigler, P.B. (1998) Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains. Proc Natl Acad Sci U S A 95, 5998-6003.

17. Williams, S.P. and Sigler, P.B. (1998) Atomic structure of progesterone complexed with its receptor. Nature 393, 392-396.

18. Lu, N.Z. and Cidlowski, J.A. (2005) Translational regulatory mechanisms generate N-terminal glucocorticoid receptor isoforms with unique transcriptional target genes. Mol Cell 18, 331-342.

19. Breslin, M.B., Geng, C.D. and Vedeckis, W.V. (2001) Multiple promoters exist in the human GR gene, one of which is activated by glucocorticoids. Mol Endocrinol 15, 1381-1395.

20. Chrousos, G.P. and Kino, T. (2005) Intracellular glucocorticoid signaling: a formerly simple system turns stochastic. Sci STKE 2005, pe48.

21. Denis, M., Gustafsson, J.A. and Wikstrom, A.C. (1988) Interaction of the Mr = 90,000 heat shock protein with the steroid-binding domain of the glucocorticoid receptor. J Biol Chem 263, 18520-18523.

22. Czar, M.J., Lyons, R.H., Welsh, M.J., Renoir, J.M. and Pratt, W.B. (1995) Evidence that the FK506-binding immunophilin heat shock protein 56 is required for trafficking of the glucocorticoid receptor from the cytoplasm to the nucleus. Mol Endocrinol 9, 1549-1560.

23. Owens-Grillo, J.K., Hoffmann, K., Hutchison, K.A., Yem, A.W., Deibel, M.R., Jr., Handschumacher, R.E. and Pratt, W.B. (1995) The cyclosporin A-binding immunophilin CyP-40 and the FK506-binding immunophilin hsp56 bind to a common site on hsp90 and exist in independent cytosolic heterocomplexes with the untransformed glucocorticoid receptor. J Biol Chem 270, 20479-20484.

24. Savory, J.G., Hsu, B., Laquian, I.R., Giffin, W., Reich, T., Hache, R.J. and Lefebvre, Y.A. (1999) Discrimination between NL1- and NL2-mediated nuclear localization of the glucocorticoid receptor. Mol Cell Biol 19, 1025-1037.

25. McNally, J.G., Muller, W.G., Walker, D., Wolford, R. and Hager, G.L. (2000) The glucocorticoid receptor: rapid exchange with regulatory sites in living cells. Science 287, 1262-1265.

26. Hache, R.J., Tse, R., Reich, T., Savory, J.G. and Lefebvre, Y.A. (1999) Nucleocytoplasmic trafficking of steroid-free glucocorticoid receptor. J Biol Chem 274, 1432-1439.

27. Yang, J., Liu, J. and DeFranco, D.B. (1997) Subnuclear trafficking of glucocorticoid receptors in vitro: chromatin recycling and nuclear export. J Cell Biol 137, 523-538.

28. DeFranco, D.B. (1997) Subnuclear trafficking of steroid receptors. Biochem Soc Trans 25, 592-597.

29. Itoh, M., Adachi, M., Yasui, H., Takekawa, M., Tanaka, H. and Imai, K. (2002) Nuclear export of glucocorticoid receptor is enhanced by c-Jun N-terminal kinase-mediated phosphorylation. Mol Endocrinol 16, 2382-2392.

30. Kino, T., Souvatzoglou, E., De Martino, M.U., Tsopanomihalu, M., Wan, Y. and Chrousos, G.P. (2003) Protein 14-3-3s interacts with and favors cytoplasmic subcellular localization of the glucocorticoid receptor, acting as a negative regulator of the glucocorticoid signaling pathway. J Biol Chem, 278, 25651-25656.

31. Holaska, J.M., Black, B.E., Love, D.C., Hanover, J.A., Leszyk, J. and Paschal, B.M. (2001) Calreticulin Is a receptor for nuclear export. J Cell Biol 152, 127-140.

32. Holaska, J.M., Black, B.E., Rastinejad, F. and Paschal, B.M. (2002) Ca2+-dependent nuclear export mediated by calreticulin. Mol Cell Biol 22, 6286-6297.

33. Bamberger, C.M., Schulte, H.M. and Chrousos, G.P. (1996) Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. Endocr Rev 17, 245-261.

34. Lieberman, B.A., Bona, B.J., Edwards, D.P. and Nordeen, S.K. (1993) The constitution of a progesterone response element. Mol Endocrinol 7, 515-527.

35. Beato, M. and Sanchez-Pacheco, A. (1996) Interaction of steroid hormone receptors with the transcription initiation complex. Endocr Rev 17, 587-609.

36. Giguere, V., Hollenberg, S.M., Rosenfeld, M.G. and Evans, R.M. (1986) Functional domains of the human glucocorticoid receptor. Cell 46, 645-652.

37. McKenna, N.J., Lanz, R.B. and O'Malley, B.W. (1999) Nuclear receptor coregulators: cellular and molecular biology. Endocr Rev 20, 321-344.

38. Goodman, R.H. and Smolik, S. (2000) CBP/p300 in cell growth, transformation, and development. Genes Dev 14, 1553-1577.

39. Yang, X.J., Ogryzko, V.V., Nishikawa, J., Howard, B.H. and Nakatani, Y. (1996) A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature 382, 319-324.

40. Blanco, J.C., Minucci, S., Lu, J., Yang, X.J., Walker, K.K., Chen, H., Evans, R.M., Nakatani, Y. and Ozato, K. (1998) The histone acetylase PCAF is a nuclear receptor coactivator. Genes Dev 12, 1638-1651.

41. Leo, C. and Chen, J.D. (2000) The SRC family of nuclear receptor coactivators. Gene 245, 1-11.

42. Glass, C.K. and Rosenfeld, M.G. (2000) The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev 14, 121-141.

43. Boyes, J., Byfield, P., Nakatani, Y. and Ogryzko, V. (1998) Regulation of activity of the transcription factor GATA-1 by acetylation. Nature 396, 594-598.

44. Gu, W. and Roeder, R.G. (1997) Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90, 595-606.

45. Chen, H., Lin, R.J., Xie, W., Wilpitz, D. and Evans, R.M. (1999) Regulation of hormone-induced histone hyperacetylation and gene activation via acetylation of an acetylase. Cell 98, 675-686.

46. Heery, D.M., Kalkhoven, E., Hoare, S. and Parker, M.G. (1997) A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature 387, 733-736.

47. Fry, C.J. and Peterson, C.L. (2001) Chromatin remodeling enzymes: who's on first? Curr Biol 11, R185-197.

48. Yoshinaga, S.K., Peterson, C.L., Herskowitz, I. and Yamamoto, K.R. (1992) Roles of SWI1, SWI2, and SWI3 proteins for transcriptional enhancement by steroid receptors. Science 258, 1598-1604.

49. Rachez, C. and Freedman, L.P. (2001) Mediator complexes and transcription. Curr Opin Cell Biol 13, 274-280.

50. Henriksson, A., Almlof, T., Ford, J., McEwan, I.J., Gustafsson, J.A. and Wright, A.P. (1997) Role of the Ada adaptor complex in gene activation by the glucocorticoid receptor. Mol Cell Biol 17, 3065-3073.

51. Wallberg, A.E., Neely, K.E., Hassan, A.H., Gustafsson, J.A., Workman, J.L. and Wright, A.P. (2000) Recruitment of the SWI-SNF chromatin remodeling complex as a mechanism of gene activation by the glucocorticoid receptor tau1 activation domain. Mol Cell Biol 20, 2004-2013.

52. Ma, H., Hong, H., Huang, S.M., Irvine, R.A., Webb, P., Kushner, P.J., Coetzee, G.A. and Stallcup, M.R. (1999) Multiple signal input and output domains of the 160-kilodalton nuclear receptor coactivator proteins. Mol Cell Biol 19, 6164-6173.

53. Webb, P., Nguyen, P., Shinsako, J., Anderson, C., Feng, W., Nguyen, M.P., Chen, D., Huang, S.M., Subramanian, S., McKinerney, E., Katzenellenbogen, B.S., Stallcup, M.R. and Kushner, P.J. (1998) Estrogen receptor activation function 1 works by binding p160 coactivator proteins. Mol Endocrinol 12, 1605-1618.

54. Wallberg, A.E., Neely, K.E., Gustafsson, J.A., Workman, J.L., Wright, A.P. and Grant, P.A. (1999) Histone acetyltransferase complexes can mediate transcriptional activation by the major glucocorticoid receptor activation domain. Mol Cell Biol 19, 5952-5959.

55. Hittelman, A.B., Burakov, D., Iniguez-Lluhi, J.A., Freedman, L.P. and Garabedian, M.J. (1999) Differential regulation of glucocorticoid receptor transcriptional activation via AF-1-associated proteins. EMBO J 18, 5380-5388.

56. Lanz, R.B., McKenna, N.J., Onate, S.A., Albrecht, U., Wong, J., Tsai, S.Y., Tsai, M.J. and O'Malley, B.W. (1999) A steroid receptor coactivator, SRA, functions as an RNA and is present in an SRC-1 complex. Cell 97, 17-27.

57. Benecke, A., Chambon, P. and Gronemeyer, H. (2000) Synergy between estrogen receptor α activation functions AF1 and AF2 mediated by transcription intermediary factor TIF2. EMBO Rep 1, 151-157.

58. Reichardt, H.M., Kaestner, K.H., Tuckermann, J., Kretz, O., Wessely, O., Bock, R., Gass, P., Schmid, W., Herrlich, P., Angel, P. and Schutz, G. (1998) DNA binding of the glucocorticoid receptor is not essential for survival. Cell 93, 531-541.

59. Cole, T.J., Blendy, J.A., Monaghan, A.P., Krieglstein, K., Schmid, W., Aguzzi, A., Fantuzzi, G., Hummler, E., Unsicker, K. and Schutz, G. (1995) Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes Dev 9, 1608-1621.

60. Reichardt, H.M., Tuckermann, J.P., Gottlicher, M., Vujic, M., Weih, F., Angel, P., Herrlich, P. and Schutz, G. (2001) Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor. EMBO J 20, 7168-7173.

61. Miner, J.N. and Yamamoto, K.R. (1991) Regulatory crosstalk at composite response elements. Trends Biochem Sci 16, 423-426.

62. Karin, M. and Chang, L. (2001) AP-1-glucocorticoid receptor crosstalk taken to a higher level. J Endocrinol 169, 447-451.

63. Barnes, P.J. and Karin, M. (1997) Nuclear factor-kB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336, 1066-1071.

64. Didonato, J.A., Saatcioglu, F. and Karin, M. (1996) Molecular mechanisms of immunosuppression and anti-inflammatory activities by glucocorticoids. Am J Respir Crit Care Med 154, S11-15.

65. Perkins, N.D. (2000) The Rel/NF-kB family: friend and foe. Trends Biochem Sci 25, 434-440.

66. McKay, L.I. and Cidlowski, J.A. (1999) Molecular control of immune/inflammatory responses: interactions between nuclear factor-kB and steroid receptor-signaling pathways. Endocr Rev 20, 435-459.

67. Caldenhoven, E., Liden, J., Wissink, S., Van de Stolpe, A., Raaijmakers, J., Koenderman, L., Okret, S., Gustafsson, J.A. and Van der Saag, P.T. (1995) Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids. Mol Endocrinol 9, 401-412.

68. Liden, J., Delaunay, F., Rafter, I., Gustafsson, J. and Okret, S. (1997) A new function for the C-terminal zinc finger of the glucocorticoid receptor. Repression of RelA transactivation. J Biol Chem 272, 21467-21472.

69. Wissink, S., van Heerde, E.C., Schmitz, M.L., Kalkhoven, E., van der Burg, B., Baeuerle, P.A. and van der Saag, P.T. (1997) Distinct domains of the RelA NF-kB subunit are required for negative cross-talk and direct interaction with the glucocorticoid receptor. J Biol Chem 272, 22278-22284.

70. McKay, L.I. and Cidlowski, J.A. (1998) Cross-talk between nuclear factor-kB and the steroid hormone receptors: mechanisms of mutual antagonism. Mol Endocrinol 12, 45-56.

71. Ito, K., Barnes, P.J. and Adcock, I.M. (2000) Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1β-induced histone H4 acetylation on lysines 8 and 12. Mol Cell Biol 20, 6891-6903.

72. Nissen, R.M. and Yamamoto, K.R. (2000) The glucocorticoid receptor inhibits NFkB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain. Genes Dev 14, 2314-2329.

73. Auphan, N., DiDonato, J.A., Rosette, C., Helmberg, A. and Karin, M. (1995) Immunosuppression by glucocorticoids: inhibition of NF-kB activity through induction of IkB synthesis. Science 270, 286-290.

74. Herrlich, P. (2001) Cross-talk between glucocorticoid receptor and AP-1. Oncogene 20, 2465-2475.

75. van Dam, H. and Castellazzi, M. (2001) Distinct roles of Jun : Fos and Jun : ATF dimers in oncogenesis. Oncogene 20, 2453-2464.

76. Kamei, Y., Xu, L., Heinzel, T., Torchia, J., Kurokawa, R., Gloss, B., Lin, S.C., Heyman, R.A., Rose, D.W., Glass, C.K. and Rosenfeld, M.G. (1996) A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85, 403-414.

77. Ihle, J.N. (2001) The Stat family in cytokine signaling. Curr Opin Cell Biol 13, 211-217.

78. Leonard, W.J. and O'Shea, J.J. (1998) Jaks and STATs: biological implications. Annu Rev Immunol 16, 293-322.

79. Grimley, P.M., Dong, F. and Rui, H. (1999) Stat5a and Stat5b: fraternal twins of signal transduction and transcriptional activation. Cytokine Growth Factor Rev 10, 131-157.

80. Stocklin, E., Wissler, M., Gouilleux, F. and Groner, B. (1996) Functional interactions between Stat5 and the glucocorticoid receptor. Nature 383, 726-728.

81. Stoecklin, E., Wissler, M., Moriggl, R. and Groner, B. (1997) Specific DNA binding of Stat5, but not of glucocorticoid receptor, is required for their functional cooperation in the regulation of gene transcription. Mol Cell Biol 17, 6708-6716.

82. Doppler, W., Windegger, M., Soratroi, C., Tomasi, J., Lechner, J., Rusconi, S., Cato, A.C., Almlof, T., Liden, J., Okret, S., Gustafsson, J.A., Richard-Foy, H., Starr, D.B., Klocker, H., Edwards, D. and Geymayer, S. (2001) Expression level-dependent contribution of glucocorticoid receptor domains for functional interaction with STAT5. Mol Cell Biol 21, 3266-3279.

83. Groner, B., Fritsche, M., Stocklin, E., Berchtold, S., Merkle, C., Moriggl, R. and Pfitzner, E. (2000) Regulation of the trans-activation potential of STAT5 through its DNA-binding activity and interactions with heterologous transcription factors. Growth Horm IGF Res 10, S15-20.

84. Aittomaki, S., Pesu, M., Groner, B., Janne, O.A., Palvimo, J.J. and Silvennoinen, O. (2000) Cooperation among Stat1, glucocorticoid receptor, and PU.1 in transcriptional activation of the high-affinity Fcg receptor I in monocytes. J Immunol 164, 5689-5697.

85. Takeda, T., Kurachi, H., Yamamoto, T., Nishio, Y., Nakatsuji, Y., Morishige, K., Miyake, A. and Murata, Y. (1998) Crosstalk between the interleukin-6 (IL-6)-JAK-STAT and the glucocorticoid-nuclear receptor pathway: synergistic activation of IL-6 response element by IL-6 and glucocorticoid. J Endocrinol 159, 323-330.

86. Zhang, Z., Jones, S., Hagood, J.S., Fuentes, N.L. and Fuller, G.M. (1997) STAT3 acts as a co-activator of glucocorticoid receptor signaling. J Biol Chem 272, 30607-30610.

87. Mayr, B. and Montminy, M. (2001) Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol 2, 599-609.

88. Stauber, C., Altschmied, J., Akerblom, I.E., Marron, J.L. and Mellon, P.L. (1992) Mutual cross-interference between glucocorticoid receptor and CREB inhibits transactivation in placental cells. New Biol 4, 527-540.

89. Chatterjee, V.K., Madison, L.D., Mayo, S. and Jameson, J.L. (1991) Repression of the human glycoprotein hormone α-subunit gene by glucocorticoids: evidence for receptor interactions with limiting transcriptional activators. Mol Endocrinol 5, 100-110.

90. Imai, E., Miner, J.N., Mitchell, J.A., Yamamoto, K.R. and Granner, D.K. (1993) Glucocorticoid receptor-cAMP response element-binding protein interaction and the response of the phosphoenolpyruvate carboxykinase gene to glucocorticoids. J Biol Chem 268, 5353-5356.

91. Liu, J.L., Papachristou, D.N. and Patel, Y.C. (1994) Glucocorticoids activate somatostatin gene transcription through co-operative interaction with the cyclic AMP signalling pathway. Biochem J 301, 863-869.

92. ten Dijke, P., Miyazono, K. and Heldin, C.H. (2000) Signaling inputs converge on nuclear effectors in TGF-β signaling. Trends Biochem Sci 25, 64-70.

93. Hata, A., Lagna, G., Massague, J. and Hemmati-Brivanlou, A. (1998) Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor. Genes Dev 12, 186-197.

94. Bai, S., Shi, X., Yang, X. and Cao, X. (2000) Smad6 as a transcriptional corepressor. J Biol Chem 275, 8267-8270.

95. Bai, S. and Cao, X. (2002) A nuclear antagonistic mechanism of inhibitory Smads in transforming growth factor-β signaling. J Biol Chem 277, 4176-4182.

96. Lin, X., Liang, Y.Y., Sun, B., Liang, M., Shi, Y., Brunicardi, F.C. and Feng, X.H. (2003) Smad6 recruits transcription corepressor CtBP to repress bone morphogenetic protein-induced transcription. Mol Cell Biol 23, 9081-9093.

97. Afrakhte, M., Moren, A., Jossan, S., Itoh, S., Sampath, K., Westermark, B., Heldin, C.H., Heldin, N.E. and ten Dijke, P. (1998) Induction of inhibitory Smad6 and Smad7 mRNA by TGF-β family members. Biochem Biophys Res Commun 249, 505-511.

98. Miyazono, K. (2000) Positive and negative regulation of TGF-β signaling. J Cell Sci 113, 1101-1109.

99. Ichijo, T., Voutetakis, A., Cotrim, A.P., Bhattachryya, N., Fujii, M., Chrousos, G.P. and Kino, T. (2005) The Smad6-histone deacetylase 3 complex silences the transcriptional activity of the glucocorticoid receptor: potential clinical implications. J Biol Chem 280, 42067-42077.

100. Lekstrom-Himes, J. and Xanthopoulos, K.G. (1998) Biological role of the CCAAT/enhancer-binding protein family of transcription factors. J Biol Chem 273, 28545-28548.

101. Nishio, Y., Isshiki, H., Kishimoto, T. and Akira, S. (1993) A nuclear factor for interleukin-6 expression (NF-IL6) and the glucocorticoid receptor synergistically activate transcription of the rat α1-acid glycoprotein gene via direct protein-protein interaction. Mol Cell Biol 13, 1854-1862.

102. Boruk, M., Savory, J.G. and Hache, R.J. (1998) AF-2-dependent potentiation of CCAAT enhancer binding protein β-mediated transcriptional activation by glucocorticoid receptor. Mol Endocrinol 12, 1749-1763.

103. De Martino, M.U., Bhattachryya, N., Alesci, S., Ichijo, T., Chrousos, G.P. and Kino, T. (2004) The glucocorticoid receptor and the orphan nuclear receptor chicken ovalbumin upstream promoter-transcription factor II interact with and mutually affect each other's transcriptional activities: implications for intermediary metabolism. Mol Endocrinol 18, 820-833.

104. Pierreux, C.E., Stafford, J., Demonte, D., Scott, D.K., Vandenhaute, J., O'Brien, R.M., Granner, D.K., Rousseau, G.G. and Lemaigre, F.P. (1999) Antiglucocorticoid activity of hepatocyte nuclear factor-6. Proc Natl Acad Sci U S A 96, 8961-8966.

105. Philips, A., Maira, M., Mullick, A., Chamberland, M., Lesage, S., Hugo, P. and Drouin, J. (1997) Antagonism between Nur77 and glucocorticoid receptor for control of transcription. Mol Cell Biol 17, 5952-5959.

106. Sengupta, S., Vonesch, J.L., Waltzinger, C., Zheng, H. and Wasylyk, B. (2000) Negative cross-talk between p53 and the glucocorticoid receptor and its role in neuroblastoma cells. EMBO J 19, 6051-6064.

107. Sengupta, S. and Wasylyk, B. (2001) Ligand-dependent interaction of the glucocorticoid receptor with p53 enhances their degradation by Hdm2. Genes Dev 15, 2367-2380.

108. Chandran, U.R., Warren, B.S., Baumann, C.T., Hager, G.L. and DeFranco, D.B. (1999) The glucocorticoid receptor is tethered to DNA-bound Oct-1 at the mouse gonadotropin-releasing hormone distal negative glucocorticoid response element. J Biol Chem 274, 2372-2378.

109. Subramaniam, N., Cairns, W. and Okret, S. (1998) Glucocorticoids repress transcription from a negative glucocorticoid response element recognized by two homeodomain-containing proteins, Pbx and Oct-1. J Biol Chem 273, 23567-23574.

110. Prefontaine, G.G., Lemieux, M.E., Giffin, W., Schild-Poulter, C., Pope, L., LaCasse, E., Walker, P. and Hache, R.J. (1998) Recruitment of octamer transcription factors to DNA by glucocorticoid receptor. Mol Cell Biol 18, 3416-3430.

111. Truss, M., Bartsch, J., Schelbert, A., Hache, R.J. and Beato, M. (1995) Hormone induces binding of receptors and transcription factors to a rearranged nucleosome on the MMTV promoter in vivo. EMBO J 14, 1737-1751.

112. Hartig, E. and Cato, A.C. (1994) In vivo binding of proteins to stably integrated MMTV DNA in murine cell lines: occupancy of NFI and OTF1 binding sites in the absence and presence of glucocorticoids. Cell Mol Biol Res 40, 643-652.

113. Archer, T.K., Cordingley, M.G., Wolford, R.G. and Hager, G.L. (1991) Transcription factor access is mediated by accurately positioned nucleosomes on the mouse mammary tumor virus promoter. Mol Cell Biol 11, 688-698.

114. Chang, T.J., Scher, B.M., Waxman, S. and Scher, W. (1993) Inhibition of mouse GATA-1 function by the glucocorticoid receptor: possible mechanism of steroid inhibition of erythroleukemia cell differentiation. Mol Endocrinol 7, 528-542.

115. Rosen, J. and Miner, J.N. (2005) The search for safer glucocorticoid receptor ligands. Endocr Rev 26, 452-464.

116. Vayssiere, B.M., Dupont, S., Choquart, A., Petit, F., Garcia, T., Marchandeau, C., Gronemeyer, H. and Resche-Rigon, M. (1997) Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit antiinflammatory activity in vivo. Mol Endocrinol 11, 1245-1255.

117. Coghlan, M.J., Jacobson, P.B., Lane, B., Nakane, M., Lin, C.W., Elmore, S.W., Kym, P.R., Luly, J.R., Carter, G.W., Turner, R., Tyree, C.M., Hu, J., Elgort, M., Rosen, J. and Miner, J.N. (2003) A novel antiinflammatory maintains glucocorticoid efficacy with reduced side effects. Mol Endocrinol 17, 860-869.

118. Schacke, H., Schottelius, A., Docke, W.D., Strehlke, P., Jaroch, S., Schmees, N., Rehwinkel, H., Hennekes, H. and Asadullah, K. (2004) Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects. Proc Natl Acad Sci U S A 101, 227-232.

119. De Bosscher, K., Vanden Berghe, W., Beck, I.M., Van Molle, W., Hennuyer, N., Hapgood, J., Libert, C., Staels, B., Louw, A. and Haegeman, G. (2005) A fully dissociated compound of plant origin for inflammatory gene repression. Proc Natl Acad Sci U S A 102, 15827-15832.

120. Miner, J.N., Tyree, C., Hu, J., Berger, E., Marschke, K., Nakane, M., Coghlan, M.J., Clemm, D., Lane, B. and Rosen, J. (2003) A nonsteroidal glucocorticoid receptor antagonist. Mol Endocrinol 17, 117-127.

121. Seckl, J.R. and Walker, B.R. (2001) Minireview: 11β-hydroxysteroid dehydrogenase type 1- a tissue-specific amplifier of glucocorticoid action. Endocrinology 142, 1371-1376.

122. Masuzaki, H., Paterson, J., Shinyama, H., Morton, N.M., Mullins, J.J., Seckl, J.R. and Flier, J.S. (2001) A transgenic model of visceral obesity and the metabolic syndrome. Science 294, 2166-70.

123. Masuzaki, H., Yamamoto, H., Kenyon, C.J., Elmquist, J.K., Morton, N.M., Paterson, J.M., Shinyama, H., Sharp, M.G., Fleming, S., Mullins, J.J., Seckl, J.R. and Flier, J.S. (2003) Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice. J Clin Invest 112, 83-90.

124. Ismaili, N. and Garabedian, M.J. (2004) Modulation of glucocorticoid receptor function via phosphorylation. Ann N Y Acad Sci 1024, 86-101.

125. Orti, E., Hu, L.M. and Munck, A. (1993) Kinetics of glucocorticoid receptor phosphorylation in intact cells. Evidence for hormone-induced hyperphosphorylation after activation and recycling of hyperphosphorylated receptors. J Biol Chem 268, 7779-7784.

126. Krstic, M.D., Rogatsky, I., Yamamoto, K.R. and Garabedian, M.J. (1997) Mitogen-activated and cyclin-dependent protein kinases selectively and differentially modulate transcriptional enhancement by the glucocorticoid receptor. Mol Cell Biol 17, 3947-3954.

127. Wang, Z., Frederick, J. and Garabedian, M.J. (2002) Deciphering the phosphorylation "code" of the glucocorticoid receptor in vivo. J Biol Chem 277, 26573-26580.

128. Miller, A.L., Webb, M.S., Copik, A.J., Wang, Y., Johnson, B.H., Kumar, R. and Thompson, E.B. (2005) p38 Mitogen-activated protein kinase (MAPK) is a key mediator in glucocorticoid-induced apoptosis of lymphoid cells: correlation between p38 MAPK activation and site-specific phosphorylation of the human glucocorticoid receptor at serine 211. Mol Endocrinol 19, 1569-1583.

129. Ismaili, N., Blind, R. and Garabedian, M.J. (2005) Stabilization of the unliganded glucocorticoid receptor by TSG101. J Biol Chem 280, 11120-11126.

130. Kino, T., Ichijo, T., Amin, N.D., Kasavapany, S., Wang, Y.-H., Kim, N., Rao, S., Player, A., Zheng, Y.-L., Garabedian, M.J., Kawasaki, E., Harish, H.C. and Chrousos, G.P. (2007) Cyclin-dependent kinase 5 differentially regulates the transcriptional activity of the glucocorticoid receptor through phosphorylation: Clinical implications for the nervous system response to glucocorticoids and stress. Mol Endocrinol 21, 1552-1568.

131. Dhavan, R. and Tsai, L.H. (2001) A decade of CDK5. Nat Rev Mol Cell Biol 2, 749-759.

132. Kino, T., Rice, K.C. and Chrousos, G.P. (2007) AMP-activated protein kinase enhances the transcriptional activity of the glucocorticoid receptor by phosphorylating serine 211 of the latter through activation of p38 MAP kinase: Is this a natural counter-regulatory mechanism? . In: Endocrine Society's 89th Annual Meeting, Tronto, Canada.

133. Kang, K.I., Meng, X., Devin-Leclerc, J., Bouhouche, I., Chadli, A., Cadepond, F., Baulieu, E.E. and Catelli, M.G. (1999) The molecular chaperone Hsp90 can negatively regulate the activity of a glucocorticosteroid-dependent promoter. Proc Natl Acad Sci U S A 96, 1439-1444.

134. Schneikert, J., Hubner, S., Langer, G., Petri, T., Jaattela, M., Reed, J. and Cato, A.C. (2000) Hsp70-RAP46 interaction in downregulation of DNA binding by glucocorticoid receptor. EMBO J 19, 6508-6516.

135. Dennis, A.P. and O'Malley, B.W. (2005) Rush hour at the promoter: how the ubiquitin-proteasome pathway polices the traffic flow of nuclear receptor-dependent transcription. J Steroid Biochem Mol Biol 93, 139-151.

136. Kinyamu, H.K., Chen, J. and Archer, T.K. (2005) Linking the ubiquitin-proteasome pathway to chromatin remodeling/modification by nuclear receptors. J Mol Endocrinol 34, 281-297.

137. Jason, L.J., Moore, S.C., Lewis, J.D., Lindsey, G. and Ausio, J. (2002) Histone ubiquitination: a tagging tail unfolds? Bioessays 24, 166-174.

138. Gillette, T.G., Gonzalez, F., Delahodde, A., Johnston, S.A. and Kodadek, T. (2004) Physical and functional association of RNA polymerase II and the proteasome. Proc Natl Acad Sci U S A 101, 5904-5909.

139. van Hemert, M.J., Steensma, H.Y. and van Heusden, G.P. (2001) 14-3-3 proteins: key regulators of cell division, signalling and apoptosis. Bioessays 23, 936-946.

140. Muslin, A.J. and Xing, H. (2000) 14-3-3 proteins: regulation of subcellular localization by molecular interference. Cell Signal 12, 703-709.

141. Widen, C., Zilliacus, J., Gustafsson, J.A. and Wikstrom, A.C. (2000) Glucocorticoid receptor interaction with 14-3-3 and Raf-1, a proposed mechanism for cross-talk of two signal transduction pathways. J Biol Chem 275, 39296-39301.

142. Wakui, H., Wright, A.P., Gustafsson, J. and Zilliacus, J. (1997) Interaction of the ligand-activated glucocorticoid receptor with the 14-3-3h protein. J Biol Chem 272, 8153-8156.

143. Stohs, S.J., Abbott, B.D., Lin, F.H. and Birnbaum, L.S. (1990) Induction of ethoxyresorufin-O-deethylase and inhibition of glucocorticoid receptor binding in skin and liver of haired and hairless HRS/J mice by topically applied 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicology 65, 123-136.

144. Sunahara, G.I., Lucier, G.W., McCoy, Z., Bresnick, E.H., Sanchez, E.R. and Nelson, K.G. (1989) Characterization of 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated decreases in dexamethasone binding to rat hepatic cytosolic glucocorticoid receptor. Mol Pharmacol 36, 239-247.

145. Brake, P.B., Zhang, L. and Jefcoate, C.R. (1998) Aryl hydrocarbon receptor regulation of cytochrome P4501B1 in rat mammary fibroblasts: evidence for transcriptional repression by glucocorticoids. Mol Pharmacol 54, 825-833.

146. Czar, M.J., Galigniana, M.D., Silverstein, A.M. and Pratt, W.B. (1997) Geldanamycin, a heat shock protein 90-binding benzoquinone ansamycin, inhibits steroid-dependent translocation of the glucocorticoid receptor from the cytoplasm to the nucleus. Biochemistry 36, 7776-7785.

147. Whitesell, L. and Cook, P. (1996) Stable and specific binding of heat shock protein 90 by geldanamycin disrupts glucocorticoid receptor function in intact cells. Mol Endocrinol 10, 705-712.

148. Makino, Y., Okamoto, K., Yoshikawa, N., Aoshima, M., Hirota, K., Yodoi, J., Umesono, K., Makino, I. and Tanaka, H. (1996) Thioredoxin: a redox-regulating cellular cofactor for glucocorticoid hormone action. Cross talk between endocrine control of stress response and cellular antioxidant defense system. J Clin Invest 98, 2469-2477.

149. Miura, T., Ouchida, R., Yoshikawa, N., Okamoto, K., Makino, Y., Nakamura, T., Morimoto, C., Makino, I. and Tanaka, H. (2001) Functional Modulation of the Glucocorticoid Receptor and Suppression of NF-kB-dependent Transcription by Ursodeoxycholic Acid. J Biol Chem 276, 47371-47378.

150. Yoshikawa, N., Makino, Y., Okamoto, K., Morimoto, C., Makino, I. and Tanaka, H. (2002) Distinct interaction of cortivazol with the ligand binding domain confers glucocorticoid receptor specificity: cortivazol is a specific ligand for the glucocorticoid receptor. J Biol Chem 277, 5529-40.

151. Takahashi, S., Wakui, H., Gustafsson, J.A., Zilliacus, J. and Itoh, H. (2000) Functional interaction of the immunosuppressant mizoribine with the 14-3-3 protein. Biochem Biophys Res Commun 274, 87-92.

152. Vingerhoeds, A.C.M., Thijssen, J.H.H. and Schwarts, F. (1976) Spontaneous hypercortisolism without Cushing's syndrome. J Clin Endocrinol Metab 43, 1128-1133.

153. Chrousos, G.P., Vingerhoeds, A., Brandon, D., Eil, C., Pugeat, M., DeVroede, M., Loriaux, D.L. and Lipsett, M.B. (1982) Primary cortisol resistance in man. A glucocorticoid receptor-mediated disease. J Clin Invest 69, 1261-1269.

154. Lamberts, S.W., Poldermans, D., Zweens, M. and de Jong, F.H. (1986) Familial cortisol resistance: differential diagnostic and therapeutic aspects. J Clin Endocrinol Metab 63, 1328-1333.

155. Nawata, H., Sekiya, K., Higuchi, K., Kato, K. and Ibayashi, H. (1987) Decreased deoxyribonucleic acid binding of glucocorticoid-receptor complex in cultured skin fibroblasts from a patient with the glucocorticoid resistance syndrome. J Clin Endocrinol Metab 65, 219-226.

156. Iida, S., Gomi, M., Moriwaki, K., Itoh, Y., Hirobe, K., Matsuzawa, Y., Katagiri, S., Yonezawa, T. and Tarui, S. (1985) Primary cortisol resistance accompanied by a reduction in glucocorticoid receptors in two members of the same family. J Clin Endocrinol Metab 60, 967-971.

157. Vecsei, P., Frank, K., Haack, D., Heinze, V., Ho, A.D., Honour, J.W., Lewicka, S., Schoosch, M. and Ziegler, R. (1989) Primary glucocorticoid receptor defect with likely familial involvement. Cancer Res 49, 2220s-2221s.

158. Lamberts, S.W., Koper, J.W., Biemond, P., den Holder, F.H. and de Jong, F.H. (1992) Cortisol receptor resistance: the variability of its clinical presentation and response to treatment. J Clin Endocrinol Metab 74, 313-321.

159. Hurley, D.M., Accili, D., Stratakis, C.A., Karl, M., Vamvakopoulos, N., Rorer, E., Constantine, K., Taylor, S.I. and Chrousos, G.P. (1991) Point mutation causing a single amino acid substitution in the hormone binding domain of the glucocorticoid receptor in familial glucocorticoid resistance. J Clin Invest 87, 680-686.

160. Karl, M., Lamberts, S.W., Detera-Wadleigh, S.D., Encio, I.J., Stratakis, C.A., Hurley, D.M., Accili, D. and Chrousos, G.P. (1993) Familial glucocorticoid resistance caused by a splice site deletion in the human glucocorticoid receptor gene. J Clin Endocrinol Metab 76, 683-689.

161. Karl, M., Lamberts, S.W., Koper, J.W., Katz, D.A., Huizenga, N.E., Kino, T., Haddad, B.R., Hughes, M.R. and Chrousos, G.P. (1996) Cushing's disease preceded by generalized glucocorticoid resistance: clinical consequences of a novel, dominant-negative glucocorticoid receptor mutation. Proc Assoc Am Physicians 108, 296-307.

162. Malchoff, D.M., Brufsky, A., Reardon, G., McDermott, P., Javier, E.C., Bergh, C.H., Rowe, D. and Malchoff, C.D. (1993) A mutation of the glucocorticoid receptor in primary cortisol resistance. J Clin Invest 91, 1918-1925.

163. Kino, T., Stauber, R.H., Resau, J.H., Pavlakis, G.N. and Chrousos, G.P. (2001) Pathologic human GR mutant has a transdominant negative effect on the wild-type GR by inhibiting its translocation into the nucleus: Importance of the ligand-binding domain for intracellular GR trafficking. J Clin Endocrinol Metab 86, 5600-5608.

164. Mendonca, B.B., Leite, M.V., de Castro, M., Kino, T., Elias, L.L., Bachega, T.A., Arnhold, I.J., Chrousos, G.P. and Latronico, A.C. (2002) Female pseudohermaphroditism caused by a novel homozygous missense mutation of the GR gene. J Clin Endocrinol Metab 87, 1805-1809.

165. Ruiz, M., Lind, U., Gafvels, M., Eggertsen, G., Carlstedt-Duke, J., Nilsson, L., Holtmann, M., Stierna, P., Wikstrom, A.C. and Werner, S. (2001) Characterization of two novel mutations in the glucocorticoid receptor gene in patients with primary cortisol resistance. Clin Endocrinol (Oxf) 55, 363-371.

166. Charmandari, E., Kino, T., Ichijo, T., Zachman, K., Alatsatianos, A. and Chrousos, G.P. (2006) Functional characterization of the natural human glucocorticoid receptor (hGR) mutants hGRαR477H and hGRαG679S associated with generalized glucocorticoid resistance. J Clin Endocrinol Metab 91, 1535-1543.

167. Vottero, A., Kino, T., Combe, H., Lecomte, P. and Chrousos, G.P. (2002) A novel, C-terminal dominant negative mutation of the GR causes familial glucocorticoid resistance through abnormal interactions with p160 steroid receptor coactivators. J Clin Endocrinol Metab 87, 2658-2667.

168. Charmandari, E., Raji, A., Kino, T., Ichijo, T., Tiulpakov, A., Zachman, K. and Chrousos, G.P. (2005) A novel point mutation in the ligand-binding domain (LBD) of the human glucocorticoid receptor (hGR) causing generalized glucocorticoid resistance: the importance of the C terminus of hGR LBD in conferring transactivational activity. J Clin Endocrinol Metab 90, 3696-3705.

169. Charmandari, E., Kino, T., Souvatzoglou, E., Vottero, A., Bhattacharyya, N. and Chrousos, G.P. (2004) Natural glucocorticoid receptor mutants causing generalized glucocorticoid resistance: molecular genotype, genetic transmission, and clinical phenotype. J Clin Endocrinol Metab 89, 1939-1949.

170. Rosmond, R., Bouchard, C. and Bjorntorp, P. (2001) Tsp509I polymorphism in exon 2 of the glucocorticoid receptor gene in relation to obesity and cortisol secretion: cohort study. BMJ 322, 652-653.

171. Huizenga, N.A., Koper, J.W., De Lange, P., Pols, H.A., Stolk, R.P., Burger, H., Grobbee, D.E., Brinkmann, A.O., De Jong, F.H. and Lamberts, S.W. (1998) A polymorphism in the glucocorticoid receptor gene may be associated with and increased sensitivity to glucocorticoids in vivo. J Clin Endocrinol Metab 83, 144-151.

172. Dobson, M.G., Redfern, C.P., Unwin, N. and Weaver, J.U. (2001) The N363S polymorphism of the glucocorticoid receptor: potential contribution to central obesity in men and lack of association with other risk factors for coronary heart disease and diabetes mellitus. J Clin Endocrinol Metab 86, 2270-2274.

173. Russcher, H., van Rossum, E.F., de Jong, F.H., Brinkmann, A.O., Lamberts, S.W. and Koper, J.W. (2005) Increased expression of the glucocorticoid receptor-A translational isoform as a result of the ER22/23EK polymorphism. Mol Endocrinol 19, 1687-1696.

174. van Rossum, E.F., Voorhoeve, P.G., te Velde, S.J., Koper, J.W., Delemarre-van de Waal, H.A., Kemper, H.C. and Lamberts, S.W. (2004) The ER22/23EK polymorphism in the glucocorticoid receptor gene is associated with a beneficial body composition and muscle strength in young adults. J Clin Endocrinol Metab 89, 4004-4009.

175. van Rossum, E.F., Koper, J.W., Huizenga, N.A., Uitterlinden, A.G., Janssen, J.A., Brinkmann, A.O., Grobbee, D.E., de Jong, F.H., van Duyn, C.M., Pols, H.A. and Lamberts, S.W. (2002) A polymorphism in the glucocorticoid receptor gene, which decreases sensitivity to glucocorticoids in vivo, is associated with low insulin and cholesterol levels. Diabetes 51, 3128-3134.

176. Syed, A.A., Irving, J.A., Redfern, C.P., Hall, A.G., Unwin, N.C., White, M., Bhopal, R.S. and Weaver, J.U. (2006) Association of glucocorticoid receptor polymorphism A3669G in exon 9β with reduced central adiposity in women. Obesity (Silver Spring) 14, 759-764.

177. Oakley, R.H., Sar, M. and Cidlowski, J.A. (1996) The human glucocorticoid receptor β isoform. Expression, biochemical properties, and putative function. J Biol Chem 271, 9550-9559.

178. Yudt, M.R., Jewell, C.M., Bienstock, R.J. and Cidlowski, J.A. (2003) Molecular origins for the dominant negative function of human glucocorticoid receptor β. Mol Cell Biol 23, 4319-4330.

179. Charmandari, E., Chrousos, G.P., Ichijo, T., Bhattacharyya, N., Vottero, A., Souvatzoglou, E. and Kino, T. (2005) The human glucocorticoid receptor (hGR) β isoform suppresses the transcriptional activity of hGRα by interfering with formation of active coactivator complexes. Mol Endocrinol 19, 52-64.

180. Leung, D.Y., Hamid, Q., Vottero, A., Szefler, S.J., Surs, W., Minshall, E., Chrousos, G.P. and Klemm, D.J. (1997) Association of glucocorticoid insensitivity with increased expression of glucocorticoid receptor β. J Exp Med 186, 1567-1574.

181. Honda, M., Orii, F., Ayabe, T., Imai, S., Ashida, T., Obara, T. and Kohgo, Y. (2000) Expression of glucocorticoid receptor β in lymphocytes of patients with glucocorticoid-resistant ulcerative colitis. Gastroenterology 118, 859-866.

182. Hamilos, D.L., Leung, D.Y., Muro, S., Kahn, A.M., Hamilos, S.S., Thawley, S.E. and Hamid, Q.A. (2001) GRβ expression in nasal polyp inflammatory cells and its relationship to the anti-inflammatory effects of intranasal fluticasone. J Allergy Clin Immunol 108, 59-68.

183. Derijk, R.H., Schaaf, M.J., Turner, G., Datson, N.A., Vreugdenhil, E., Cidlowski, J., de Kloet, E.R., Emery, P., Sternberg, E.M. and Detera-Wadleigh, S.D. (2001) A human glucocorticoid receptor gene variant that increases the stability of the glucocorticoid receptor β-isoform mRNA is associated with rheumatoid arthritis. J Rheumatol 28, 2383-2388.

184. de Lange, P., Segeren, C.M., Koper, J.W., Wiemer, E., Sonneveld, P., Brinkmann, A.O., White, A., Brogan, I.J., de Jong, F.H. and Lamberts, S.W. (2001) Expression in hematological malignancies of a glucocorticoid receptor splice variant that augments glucocorticoid receptor-mediated effects in transfected cells. Cancer Res 61, 3937-3941.

185. Whorwood, C.B., Donovan, S.J., Wood, P.J. and Phillips, D.I. (2001) Regulation of glucocorticoid receptor α and β isoforms and type I 11β-hydroxysteroid dehydrogenase expression in human skeletal muscle cells: a key role in the pathogenesis of insulin resistance? J Clin Endocrinol Metab 86, 2296-2308.

186. Longui, C.A., Vottero, A., Adamson, P.C., Cole, D.E., Kino, T., Monte, O. and Chrousos, G.P. (2000) Low glucocorticoid receptor α/β ratio in T-cell lymphoblastic leukemia. Horm Metab Res 32, 401-406.

187. Simpson, D.M. and Bender, A.N. (1988) Human immunodeficiency virus-associated myopathy: analysis of 11 patients. Ann Neurol 24, 79-84.

188. Kotler, D.P., Rosenbaum, K., Wang, J. and Pierson, R.N. (1999) Studies of body composition and fat distribution in HIV-infected and control subjects. J Acquir Immune Defic Syndr Hum Retrovirol 20, 228-237.

189. Yanovski, J.A., Miller, K.D., Kino, T., Friedman, T.C., Chrousos, G.P., Tsigos, C. and Falloon, J. (1999) Endocrine and metabolic evaluation of human immunodeficiency virus-infected patients with evidence of protease inhibitor-associated lipodystrophy. J Clin Endocrinol Metab 84, 1925-1931.

190. Hadigan, C., Miller, K., Corcoran, C., Anderson, E., Basgoz, N. and Grinspoon, S. (1999) Fasting hyperinsulinemia and changes in regional body composition in human immunodeficiency virus-infected women. J Clin Endocrinol Metab 84, 1932-1937.

191. Dube, M.P. (2000) Disorders of Glucose Metabolism in Patients Infected with Human Immunodeficiency Virus. Clin Infect Dis 31, 1467-1475.

192. Pavlakis, G.N. (1996) The molecular biology of HIV-1. In: AIDS: Diagnosis, Treatment and Prevention (DeVita, V.T. et al., eds.), pp. 45-74, Lippincott Raven, Philadelphia.

193. Emerman, M. (1996) HIV-1, Vpr and the cell cycle. Curr Biol 6, 1096-1103.

194. Kino, T., Gragerov, A., Kopp, J.B., Stauber, R.H., Pavlakis, G.N. and Chrousos, G.P. (1999) The HIV-1 virion-associated protein vpr is a coactivator of the human glucocorticoid receptor. J Exp Med 189, 51-62.

195. Kino, T., Gragerov, A., Slobodskaya, O., Tsopanomichalou, M., Chrousos, G.P. and Pavlakis, G.N. (2002) Human immunodeficiency virus type-1 (HIV-1) accessory protein Vpr induces transcription of the HIV-1 and glucocorticoid-responsive promoters by binding directly to p300/CBP coactivators. J Virol 76, 9724-9734.

196. Levy, D.N., Refaeli, Y., MacGregor, R.R. and Weiner, D.B. (1994) Serum Vpr regulates productive infection and latency of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A 91, 10873-10877.

197. Henklein, P., Bruns, K., Sherman, M.P., Tessmer, U., Licha, K., Kopp, J., de Noronha, C.M., Greene, W.C., Wray, V. and Schubert, U. (2000) Functional and structural characterization of synthetic HIV-1 vpr that transduces cells, localizes to the nucleus, and induces G2 cell cycle arrest. J Biol Chem 275, 32016-32026.

198. Mirani, M., Elenkov, I., Volpi, S., Hiroi, N., Chrousos, G.P. and Kino, T. (2002) HIV-1 protein Vpr suppresses IL-12 production from human monocytes by enhancing glucocorticoid action: potential implications of Vpr coactivator activity for the innate and cellular immunity deficits observed in HIV-1 infection. J Immunol 169, 6361-6368.

199. Jeang, K.T., Xiao, H. and Rich, E.A. (1999) Multifaceted activities of the HIV-1 transactivator of transcription, Tat. J Biol Chem 274, 28837-28840.

200. Kino, T. and Chrousos, G.P. (2001) Glucocorticoid and mineralocorticoid resistance/hypersensitivity syndromes. J Endocrinol 169, 437-445.

201. Kino, T., Slobodskaya, O., Pavlakis, G.N. and Chrousos, G.P. (2002) Nuclear receptor coactivator p160 proteins enhance the HIV-1 long terminal repeat promoter by bridging promoter-bound factors and the Tat-P-TEFb complex. J Biol Chem 277, 2396-2405.

202. Price, D.H. (2000) P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II. Mol Cell Biol 20, 2629-2634.

203. Fawell, S., Seery, J., Daikh, Y., Moore, C., Chen, L.L., Pepinsky, B. and Barsoum, J. (1994) Tat-mediated delivery of heterologous proteins into cells. Proc Natl Acad Sci U S A 91, 664-668.

204. Kino, T., Mirani, M., Alesci, S. and Chrousos, G.P. (2003) AIDS-Related Lipodystrophy/Insulin Resistance Syndrome. Horm Metab Res 35, 129-136.

205. Liu, C. (1991) Adenoviruses. In: Textbook of human virology (Belshe, R.B., ed.), Mosby-Year Book, Inc., St. Louis.

206. Brockmann, D. and Esche, H. (2003) The multifunctional role of E1A in the transcriptional regulation of CREB/CBP-dependent target genes. Curr Top Microbiol Immunol 272, 97-129.

207. Chinnadurai, G. (2002) CtBP, an unconventional transcriptional corepressor in development and oncogenesis. Mol Cell 9, 213-224.

208. Kino, T. and Chrousos, G.P. (2002) Tissue-specific glucocorticoid resistance-hypersensitivity syndromes: multifactorial states of clinical importance. J Allergy Clin Immunol 109, 609-613.

209. Burris, T.P. (2001) The nuclear receptor superfamily. In: Nuclear receptors and genetic disease (Burris, T.P. and McCabe, E.R.B., eds.), pp. 1-58, Academic Press, London.

210. Luisi, B.F., Xu, W.X., Otwinowski, Z., Freedman, L.P., Yamamoto, K.R. and Sigler, P.B. (1991) Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature 352, 497-505.

211. Charmandari, E., Kino, T. and Chrousos, G.P. (2004) Familial/sporadic glucocorticoid resistance: clinical phenotype and molecular mechanisms. Ann N Y Acad Sci 1024, 168-181.

212. Kino, T., De Martino, M.U., Charmandari, E., Mirani, M. and Chrousos, G.P. (2003) Tissue glucocorticoid resistance/hypersensitivity syndromes. J Steroid Biochem Mol Biol 85, 457-467.

213. Kino, T. and Chrousos, G.P. (2007) Virus-mediated modulation of the host endocrine signaling systems: clinical implications. Trends Endocrinol Metab 18, 159-166.

214. Charmandari, E. and Kino, T. (2007) Novel causes of generalized glucocorticoid resistance. Horm Metab Res 39, 445-450.